In the absence of monocytes, NK cells from cancer patients exhibited decreased cytotoxic function when treated with IL-2 alone (Figure 2A and Figure S2A), or IL-2+anti-CD16 mAbs (Figure 2B and Figure S2B), or IL-2 + sAJ2 (Figure 2C and Figure S2C). Here, IL2 is linked to cancer.